Daraxonrasib
Also called Rasonque.
An investigational cancer medicine that targets RAS, one of the most commonly mutated genes in human tumours and long considered undruggable.
Sources and notes
- The introductionfrom sourceMoleculeFinder curated
- Other namesfrom sourcePubChem / Wikidata
- Formula and weightcomputedPubChem
- 2D drawingcomputedPubChem structure, drawn by RDKit
Where you encounter it
Dispensed on prescription, not sold on a shelf.
Sources and notes
- The line abovefrom sourceMoleculeFinder curatedFrom the group the molecule belongs to.
Explore its structure
Choose a part to light it up.
An ester closed into a ring: the C=O carbon and the oxygen beside it are both ring atoms. Like any ester, it can be split by water, which opens the ring.
From: standard chemistry.
A C=O bonded to a nitrogen, the same link that joins amino acids in a protein. It is sturdy, and its nitrogen is not a base the way an amine's is.
From: standard chemistry.
A nitrogen bonded to three carbons, with no hydrogen of its own. Its spare pair of electrons can still pick up a hydrogen ion, so a tertiary amine is a base.
From: standard chemistry.
Sources and notes
- The drawingcomputedPubChem structure, drawn by RDKitThe page's one shipped drawing, with the chosen part lit in amber under it.
- The partscomputedFound by ruleEach part is found by a chemical pattern, never picked by hand atom by atom; its words say where they come from.
Properties and sources
Calculated by PubChem
- Molecular formula
- C44H58N8O5S
- Molecular weight
- 811 g/mol
- XLogP3octanol/water, log units
- 5.1
- Polar surface areatopological
- 162 Ų
- H-bond donors
- 2
- H-bond acceptors
- 11
- Rotatable bonds
- 7
- Complexity
- 1470
Reported Licence
The US Food and Drug Administration licenses Daraxonrasib for human use (NDA 220910, authorized August 26, 2026), as Rasonque. Drugs@FDA
Groups it belongs to
- Category
- Prescription medicine
- Family
- Cancer medicines
CCN1C2=C3C=C(C=C2)C4=CSC(=N4)C[C@@H](C(=O)N5CCC[…134 charactersPubChem CID 164726578 · Wikidata Q136659312 · InChIKey FVICRBSEYSHKFY-JYQNNKODSA-N · Data refreshed
Questions
- What is Daraxonrasib?
- An investigational cancer medicine that targets RAS, one of the most commonly mutated genes in human tumours and long considered undruggable.
- What kind of molecule is Daraxonrasib?
- Daraxonrasib has the formula C44H58N8O5S and a molecular weight of 811 g/mol. MoleculeFinder files it under cancer medicines, in the prescription medicine group. from sourcefrom sourcefrom sourcefrom source
- Who licenses Daraxonrasib as a medicine?
- The US Food and Drug Administration licenses Daraxonrasib for human use (NDA 220910, authorized August 26, 2026), as Rasonque. from source
Sources and notes
- Calculated valuescomputedPubChemComputed from the structure, so no laboratory conditions apply; complexity is PubChem's own structural score.
- Licencefrom sourceDrugs@FDARead 2026-10-21.
- Data refreshedfrom sourceMoleculeFinder2026-11-09